Chimeric Antigen Receptor (CAR) T-cell therapyheme malignanciessolid tumorsUniversity of PittsburghLohmueller Lab
…Background While Chimeric Antigen Receptor (CAR) T-cell therapy has revolutionized the treatment of heme malignancies, multiple…
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 1,201–1,260 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
Ketone supplementation1LDLT1MBSR1MRI1MSAA1NeoExpand1OTSC1PAH-targeted therapy1PBMT-sMF1PED Shield1PET-CT1PF1Paravertebral blocks1SACB1STRETCH1TCAR1TESDT1TG-PRK + CXL1arthroplasty1cardio-oncology1chemotherapy-induced oral mucositis1clinical hypnotherapy1conventional TAE1dual checkpoint blockade1local anesthesia1low FODMAP diet1lumbar punctures1neoadjuvant IO1parasternal block1popliteal plexus block1valvuloplasty13DR1ADAPT1AIDI1Anti-H. pylori treatment1B-cell targeted therapies1Biofeedback1CADx1CBTaR1CETA1Cast immobilisation1Contour-assisted coiling1DOR/3TC/TDF1DSD1De-escalation1Digital psychotherapies1EBRT1ENRICH1ERAS1EUS-RFA1External aortic compression1GP regimen1HEMT1HTx1ISBTx1Intraosseous devices1KPE1LDN therapy1LST1Locoregional delivery1
Articles mentioning treatments
7,227 articles · page 503 of 603anti-PD1 therapycancerPrinceton UniversityMC38 colorectal tumors
…ain their renewal capacity and are the responding population to anti-PD1 therapy. Currently it is unknown if obesity and aging lead to the same …
adoptive cell therapymelanomasolid tumors
…ymphocytes (TILs) have yielded promising clinical results as an adoptive cell therapy for numerous solid tumors. Recently, TIL therapy received regul…
cancer treatmentThe Scripps Research InstituteNeu5AcScripps General Clinical Research CenterTSRIUC San DiegoN-acetylneuraminic acidUCSDsolid malignanciesUC San Diego Moores Cancer Center+1 more
…the tumor microenvironment (TME) impose substantial barriers to cancer treatment. Many solid malignancies create a hyperosmotic TME due to incre…
ImmunotherapyAMLB-ALL
…Background Immunotherapy has emerged as an attractive approach to improve outcomes for p…
cancer immunotherapylung and colon cancerBTN1A1Galectin-9
…unoregulatory molecule with potential utility as a biomarker in cancer immunotherapy. While previous studies have demonstrated BTN1A1’s role in modu…
Cancer immunotherapybreast cancerSNUBHhuman breast cancerSeoul National University Bundang HospitalKorea Advanced Institute of Science and Technology
…Background Cancer immunotherapy harnesses the immune system to recognise and eliminate cancer c…
platinum-based chemotherapytarlatamabMayo Clinic Rochestersmall cell lung cancerFDA
…mall cell lung cancer (SCLC) with disease progression following platinum-based chemotherapy and at least one other prior line of therapy. We aim to examine…
97.8%
immunomodulatory therapyUniversity of the PacificNIGMSOral squamous cell carcinoma (OSCC)Arthur A. Dugoni School of DentistryOSCC
…provide unprecedented opportunities for biomarker discovery and immunomodulatory therapy. We hypothesized that imaging mass cytometry (IMC), a high-dime…
regenerative medicineHEK293HEK293-expressedHEK293-derivedE. coliIL-15IL-7IL-34Brain-derived neurotrophic factor
…d growth factors are critical reagents used in cell therapy and regenerative medicine, yet their biological activity and consistency can vary signifi…
Cancer immunotherapiesNC State UniversityB16F10 melanomasMOC1 squamous cell carcinomasXCSgelXCSgel-IL12Chancellor’s Innovation Fund
…Background Cancer immunotherapies, although they can confer potent and durable antitumor effects,…
supportive therapyThymomodulinThymus extractEuropean Unionimmune dysregulationThymosinLubelskie Regional Programme RPLUreactivated human alphaherpesvirus1 infectionsThymicPeptides
…nd the synthetic analogues of thymosins as well as their use in supportive therapy in different disorders have been documented in immune dysregula…